Nasdaq
KRYS
Krystal Biotech, Inc.
- Health Care
- Listed 2017
- 1 day
- −0.9%
- 1 month
- −12.5%
- 1 year
- +137%
$322.69 · Mkt cap $9.55B · P/E 47.18
At the 6 Aug 2026 close
Nasdaq
Krystal Biotech, Inc.
$322.69 · Mkt cap $9.55B · P/E 47.18
At the 6 Aug 2026 close
Krystal Biotech, Inc. trades under the ticker KRYS on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2017. Its market capitalisation is $9.55B. The last closing price was $322.69, on 6 Aug 2026. It trades at 47.18 times its last reported annual diluted earnings per share. Over the past year the share price is +137%, and −12.5% over the past month. Returns are price returns and exclude dividends.
This page exists because KRYS is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.